8
panel
FasterCures Advisory Councils Meeting (Invite only)
This meeting brings together the FasterCures Advisory Groups—including the Board, Business Counc
il, and Changemakers nonprofit advisory council—to discuss timely topics across the biomedical research ecosystem.
+ Read More
staff
Brenda Huneycutt, PhD
Brenda Huneycutt, PhD, is a senior director at the Milken Institute, where she directs the expans
ion of MI Health programmatic work internationally across all MI Health portfolios.
+ Read More
panel
FasterCures Private Dinner (Invite only)
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
article
Does it Work for Patients? A Multi-Step Approach to Defining Performance and Measuring Progress Across the Biomedical Ecosystem
Quick Links
Step One: Discover Existing Research »
Step Two: Articulate Ideals»
Step Three: Ident
ify Measures »
+ Read More
article
Patient Organizations as Research and Data Partners
What data assets are patient organizations creating, and how are they adding value to the work of pa
rtners trying to accelerate therapeutic development for patients?
+ Read More
article
Milken Institute Announces Key Initiatives at the 2024 Global Conference to Shape the Future of Health
Esther Krofah, executive vice president of Milken Institute Health, (pictured at left) with Emma Wal
msley, CEO of GSK, (right) at the 2024 Milken Institute Global Conference.
+ Read More
article
Pediatric Biomarkers: A Slow Zone for Patients
Q. When it comes to oncology, what is one specific example of how the system is not performing well
for patients, in other words, a Slow Zone?
+ Read More